SOBR Safe raises $3.1M via warrant exercise to fund merger, save Nasdaq listing
What's the deal? SOBR SafeDealroom has a profile for this one. Try Dealroom → (Nasdaq: SOBR) has raised roughly $3.1 million in gross proceeds through a private placement tied to the immediate exercise of outstanding warrants. Holders agreed to exercise warrants for up to 2,360,648 shares — originally issued in December 2025 at $1.30 — at a reduced price of $1.05 per share. H.C. WainwrightDealroom has a profile for this one. Try Dealroom → & Co. acted as exclusive placement agent.
How it works: In exchange for exercising early and paying an extra $0.125 per new warrant — adding $590,162 to gross proceeds — SOBRsafe will issue new unregistered Series E and Series F warrants. Both carry a $1.30 exercise price and are exercisable immediately, expiring in five years and 24 months, respectively.
Why now? The Denver company said the raise strengthens its balance sheet to support a proposed merger and helps it regain Nasdaq listing compliance. The offering was expected to close on or about July 16, 2026.
What's the endgame? SOBRsafe builds transdermal, touch-based alcohol detection technology that reads alcohol emitted through a user's skin — no breath, blood, or urine sample needed. It targets the behavioral health, family law, and consumer markets. The company plans to use net proceeds for working capital and general corporate purposes.
What could go wrong? The closing remained subject to customary conditions, and the new warrants are unregistered — SOBRsafe has agreed to file a resale registration statement with the Securities and Exchange Commission. Both the merger and full Nasdaq compliance are still to be secured.
The signal: Warrant repricing is a common lever for small-cap firms needing cash fast without a fresh equity raise. For SOBRsafe, the $3.1 million is less about growth capital and more about buying runway to close a deal and stay listed.
Read more: finanznachrichten.de
Image credit: Generated with Gemini
